. . . . . . . "[Furthermore, JAK2 mutation screening has now become a front-line diagnostic test in the evaluation of both 'erythrocytosis' and thrombocytosis and the 2001 World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis have now been revised to incorporate JAK2V617F mutation screening.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:14:04+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .